Hims & Hers Health Projects 2026 Revenue in Line with Wall Street Expectations

Hims & Hers Health has projected its revenue for 2026 to align with Wall Street's expectations. Bloomberg posted on X that this forecast is contingent upon the company's ability to continue selling generic weight loss medications, which are currently facing legal and regulatory challenges. The company's reliance on these products highlights the potential risks involved in meeting its financial targets. source: https://www.binance.com/en/square/post/294878753167025?utm_source=BinanceNewsRSS